ARCHIVES

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

Clinical Trials Approved By NCI

November 26, 2010

Senate Confirms McClellan For FDA

October 25, 2002